Nils Hansen's Biography

Nils Hansen, Chief Executive Officer, Vipergen ApS

Dr. Nils Hansen is the CEO and founder of Vipergen ApS. He is the principal inventor of the enabling YoctoReactor® and Binder Trap Enrichment® drug discovery technology platforms. He previously worked for Praecis Pharmaceuticals Inc., (Waltham, MA, USA) and Symphogen A/S, (Copenhagen, Denmark). Dr. Hansen earned his Ph.D. in immunology from the University of Copenhagen, Denmark in 2000 and his M.Sc. in Chemistry and Biotechnology from the University of Aarhus, Denmark in 1996.

The First Discovery of a Single Digit Nanomolar Small Molecule Blocker of a Protein-protein Interaction Target

Wednesday, 18 February 2015 at 15:00

Add to Calendar ▼2015-02-18 15:00:002015-02-18 16:00:00Europe/LondonThe First Discovery of a Single Digit Nanomolar Small Molecule Blocker of a Protein-protein Interaction TargetDiscovery Chemistry Congress in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com

Effective small molecule PPI blocker discovery using high fidelity DNA-encoded libraries and a low-noise homogeneous screening assay. The screen employs a unique principle of trapping small molecule binders together with the protein target in miniscule droplets.

Add to Calendar ▼2015-02-17 00:00:002015-02-18 00:00:00Europe/LondonDiscovery Chemistry CongressDiscovery Chemistry Congress in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com

#SBDCC2015 Tweets

Conference Sponsors